Sign in
4

Changes in Ownership

GALECTIN THERAPEUTICS INC Filed Acc 0000899243-21-013810

Options or other derivatives

  • Chief Financial Officer acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

CALLICUTT JACK W · Chief Financial Officer

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-03-25 Grant or award : show line 1 in the form Stock option (right to buy) +50,000 $2.11 2031-03-25 50,000 50,000 D
2021-03-25 Grant or award : show line 2 in the form Stock option (right to buy) +100,000 $2.11 2031-03-25 100,000 100,000 D
Loading xslF345X03/doc4.xml…